Inclusion Criteria:  Pregnant women with a positive SARS-CoV-2 antigen test and a confirmatory positive SARS-CoV-2 PCR test.  Exclusion Criteria:  on regular ASA administration on long-term non-steroidal anti-inflammatory medication bleeding disorders such as Von Willebrand's disease history of peptic ulceration history of hypersensitivity to ASA participation in another clinical trial inability to cooperate with the requirements of the study severe COVID-19 disease (with any of the following: respiratory rate > 30 breaths/min; severe respiratory distress; SpO2 ≤ 93% on room air; acute respiratory distress syndrome; sepsis with acute organ dysfunction). treatment resistant hyperemesis gravidarum